MARKET

PFE

PFE

Pfizer
NYSE

Real-time Quotes | Nasdaq Last Sale

33.82
+0.07
+0.21%
After Hours: 33.62 -0.2 -0.59% 19:59 02/25 EST
OPEN
33.82
PREV CLOSE
33.75
HIGH
34.11
LOW
33.54
VOLUME
37.46M
TURNOVER
--
52 WEEK HIGH
43.08
52 WEEK LOW
26.43
MARKET CAP
188.04B
P/E (TTM)
20.32
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Weekly Watchlist: Vaccines Could End the Covid Pandemic, Experts Say
Greetings, Quicktake readers! This week, vaccines from Pfizer and Johnson & Johnson spur hope for herd immunity. Plus, a turning point in the battle over Trump's tax returns. Stream now for free.
Bloomberg · 46m ago
Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister
The Ecuadorian government said on Thursday it had negotiated the purchase of 2 million doses of COVID-19 vaccines with Chinese pharmaceutical company Sinovac, which would allow authorities to start a mass inoculation process in the coming weeks. The Andea...
Reuters · 2h ago
FDA allows storage, transport of Pfizer vaccine at higher temperatures
The U.S. Food and Drug Administration on Thursday approved storage and transportation of COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE at standard freezer temperatures for up to two weeks instead of ultra-cold conditions.
Reuters · 3h ago
UPDATE 1-Brazil COVID-19 death toll passes a quarter million
reuters.com · 3h ago
Pfizer: FDA eases ultra-low temperature requirements for COVID-19 vaccine
Pfizer Inc. undefined said late Thursday the U.S. Food and Drug Administration is allowing the company "more flexible" storage and transportation conditions...
MarketWatch · 3h ago
New York officials, others downplay concern over new coronavirus variant
reuters.com · 4h ago
Pfizer joins Moderna to predict a flu-like market for COVID-19 vaccines
Today, Pfizer ([[PFE]] -0.5%) and BioNTech SE ([[BNTX]] -2.5%) announced the commencement of a clinical trial to evaluate a third dose of their COVID-19 vaccine to understand its booster effect against
Seekingalpha · 4h ago
Brazil facing mutated virus that is three times more contagious -health minister
reuters.com · 4h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PFE. Analyze the recent business situations of Pfizer through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 22 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PFE stock price target is 41.09 with a high estimate of 53.00 and a low estimate of 36.00.
EPS
Institutional Holdings
Institutions: 2.94K
Institutional Holdings: 3.71B
% Owned: 66.80%
Shares Outstanding: 5.56B
TypeInstitutionsShares
Increased
1.21K
107.88M
New
356
-9.79M
Decreased
887
225.79M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.83%
Pharmaceuticals & Medical Research
-1.34%
Key Executives
Chairman/Chief Executive Officer/Director
Albert Bourla
President
John Young
Chief Financial Officer/Executive Vice President
Frank D'Amelio
Corporate Executive
Angela Hwang
Chief Human Resource Officer/Executive Vice President
Dawn Rogers
Executive Vice President/Chief Technology Officer
Lidia Fonseca
Executive Vice President/Chief Compliance Officer/Chief Risk Officer
Rady Johnson
Executive Vice President/General Counsel
Douglas Lankler
Executive Vice President
Alexander Mackenzie
Executive Vice President
Sally Susman
Senior Vice President/Chief Accounting Officer/Controller
Jennifer Damico
Senior Vice President
Gordon Loh
Chief Scientific Officer
Mikael Dolsten
Lead Director/Independent Director
Shantanu Narayen
Director
Susan Desmond-Hellmann
Independent Director
Ronald Blaylock
Independent Director
Joseph Echevarria
Independent Director
W. Don Cornwell
Independent Director
Wyllie Cornwell
Independent Director
Scott Gottlieb
Independent Director
Helen Hobbs
Independent Director
Susan Hockfield
Independent Director
Dan Littman
Independent Director
Suzanne Nora Johnson
Independent Director
James Quincey
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
12/11/2020
Dividend USD 0.39
01/28/2021
09/24/2020
Dividend USD 0.38
11/05/2020
06/25/2020
Dividend USD 0.38
07/30/2020
04/23/2020
Dividend USD 0.38
05/07/2020
12/16/2019
Dividend USD 0.38
01/30/2020
09/24/2019
Dividend USD 0.36
11/07/2019
06/27/2019
Dividend USD 0.36
08/01/2019
04/25/2019
Dividend USD 0.36
05/09/2019
12/14/2018
Dividend USD 0.36
01/31/2019
09/27/2018
Dividend USD 0.34
11/08/2018
06/28/2018
Dividend USD 0.34
08/02/2018
04/26/2018
Dividend USD 0.34
05/10/2018
12/18/2017
Dividend USD 0.34
02/01/2018
09/27/2017
Dividend USD 0.32
11/09/2017
06/23/2017
Dividend USD 0.32
08/02/2017
04/28/2017
Dividend USD 0.32
05/10/2017
12/13/2016
Dividend USD 0.32
02/01/2017
09/23/2016
Dividend USD 0.3
11/08/2016
06/23/2016
Dividend USD 0.3
08/03/2016
04/28/2016
Dividend USD 0.3
05/11/2016
12/16/2015
Dividend USD 0.3
02/03/2016
09/25/2015
Dividend USD 0.28
11/04/2015
06/25/2015
Dividend USD 0.28
08/05/2015
04/23/2015
Dividend USD 0.28
05/06/2015
12/17/2014
Dividend USD 0.28
02/04/2015
10/24/2014
Dividend USD 0.26
11/05/2014
06/26/2014
Dividend USD 0.26
07/30/2014
04/25/2014
Dividend USD 0.26
05/07/2014
12/17/2013
Dividend USD 0.26
02/05/2014
10/25/2013
Dividend USD 0.24
11/06/2013
06/28/2013
Dividend USD 0.24
07/31/2013
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Webull offers kinds of Pfizer Inc. stock information, including NYSE:PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.